ERAS Erasca Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ERAS

Price (delayed)

$13.27

Market cap

$4.13B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.93

Enterprise value

$4.13B

?
Relative Growth: Rel. Growth: 0
Relative Strength: Rel. Strength: 99
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 2
Highlights
The equity has increased by 21% since the previous quarter
The debt is down by 10% year-on-year and by 2.5% since the previous quarter
The company's net income has shrunk by 122% QoQ and by 76% YoY
Erasca's EPS has shrunk by 111% QoQ and by 55% YoY
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ERAS

ERAS stock price

How has the Erasca stock price performed over time
Intraday
0.68%
1 week
8.77%
1 month
30.87%
1 year
767.32%
YTD
256.72%
QTD
-17.99%

Financial performance

How have Erasca's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$293.19M
Net income
-$277.02M
Gross margin
N/A
Net margin
N/A
The company's net income has shrunk by 122% QoQ and by 76% YoY
The company's operating income has shrunk by 108% QoQ and by 66% YoY

Price vs fundamentals

How does ERAS's price correlate with its fundamentals

Growth

What is Erasca's growth rate over time

Valuation

What is Erasca stock price valuation
P/E
N/A
P/B
10.48
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Erasca's EPS has shrunk by 111% QoQ and by 55% YoY
The P/B is 121% more than the last 4 quarters average of 4.7
The equity has increased by 21% since the previous quarter

Efficiency

How efficient is Erasca business performance
ERAS's ROA has dropped by 124% since the previous quarter and by 107% year-on-year
Erasca's return on equity has shrunk by 123% QoQ and by 110% YoY
ERAS's return on invested capital has dropped by 122% since the previous quarter and by 99% year-on-year

Dividends

What is ERAS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ERAS.

Financial health

How did Erasca financials performed over time
The current ratio has decreased by 23% YoY and by 5% QoQ
ERAS's quick ratio is down by 23% YoY and by 6% QoQ
The debt is 88% smaller than the equity
The equity has increased by 21% since the previous quarter
The debt to equity has decreased by 14% from the previous quarter and by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.